Asset
Dazucorilant
Corcept Therapeutics Incorporated Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04994743 | phase1 | completed | 2021-07-13 | 2021-09-30 | Corcept Therapeutics | Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants |
FDA applications (0)
This company has no applications containing this asset.